• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

bioMérieux S.A.. (4/19/18). "Press Release: bioMérieux – First-Quarter 2018 Business Review".

	Organisation	bioMérieux S.A. (Euronext: BIM)
	Group	Mérieux (Group)
	Organisation 2	Astute Medical Inc.
	Group	Mérieux (Group)
	Product	in vitro diagnostics (IVD)
	Product 2	immunoassay (diagnostics, antibody-antigen-test)
	Index term	Astute Medical–Mérieux: investment, 201804 acquisition $90m in cash by bioMérieux
	Person	Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Strong sales dynamic in first-quarter 2018, with sales up 12.5% at constant exchange rates and scope of consolidation:

>> €587 million in sales
>> Up 3.4% as reported

> Growth driven by molecular biology in the context of an intense flu season in the United States, and by buoyant business in the Asia-Pacific region


Alexandre Mérieux, Chairman and Chief Executive Officer, said: “In the first quarter, bioMérieux delivered a sound commercial performance. The recent acquisition of Astute Medical will strengthen bioMérieux’s commitment and position in immunoassays and is a perfect fit with our strategy of developing high medical value tests in order to improve patient care.”

Download [ FULL RELEASE at http://www.biomerieux.com/sites/corporate/files/news-event-press-release/biomerieux_pr_sales_q1_2018.pdf ]

Record changed: 2018-05-28

Advertisement

More documents for Mérieux (Group)

• [1] bioMérieux S.A.. (6/6/19). "Press Release: bioMérieux Increases Its Holding in Hybiome from 54% to 67%". Marcy l’Étoile....
• [2] bioMérieux S.A.. (4/24/19). "Press Release: bioMérieux – First-Quarter 2019 Business Review". Marcy l’Étoile....
• [3] bioMérieux S.A.. (4/15/19). "Press Release: “Global-PPS”, a Survey of Antibiotic Use and Bacterial Resistance in Hospitals Worldwide, Tops the 200,000 Patients". Marcy l’Étoile & Antwerp....
• [4] bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile....
• [5] bioMérieux S.A.. (3/19/19). "Press Release: Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury". Deerfield, IL & Marcy l’Etoile....
• [6] bioMérieux S.A.. (2/27/19). "Press Release: bioMérieux – 2018 Financial Results"....
• [7] bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile....
• [8] bioMérieux S.A.. (11/13/18). "Press Release: bioMérieux Launches the BioFire FilmArray Pneumonia Panels with FDA Clearance and CE Marking". Marcy l’Étoile....
• [9] bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile....
• [10] bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.